BDCM yields 18248.18% · PFE yields 6.20%● Live data
📍 BDCM pulled ahead of the other in Year 1
Combined, BDCM + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BDCM + PFE for your $10,000?
LocatI Global Holdings, Inc. develops and licenses global positioning systems (GPS) for tracking, monitoring, surveillance, and recovering automobiles, tractor-trailers, individuals, pets, cargo, medical equipment, ATMs, and electronic equipment. It offers automobile anti-theft tracking devices for tracking location and speed, setting geographic fencing, access via cell or computer, remote locking and unlocking, pinpoint road mapping, and the instant notification of vehicles; and asset protection/loss devices that provide mechanism for businesses to real time access to physical inventory. The company also provides recreation GPS tracking devices that are designed for motorcycles and all-terrain vehicles in the United States, Canada, and Mexico; boat/vessel tracking/monitoring devices to monitor boats and locations; pet tracking and recovery devices for monitoring pets; and personal tracking devices for monitoring people in real time. In addition, it offers electronic equipment protection and recovery devices for cell phones, notebooks, laptops, and desktop computers. The company's products are sold through motorcycle and all-terrain vehicle distributors, as well as automotive retailers; marine stores and boat manufacturers; and veterinarians and large box and pet supply stores. LocatI Global Holdings, Inc. was incorporated in 2011 and is based in Henderson, Nevada.
Full BDCM Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.